Skip to content

Axogen AXGN Net gains (losses) on investments

Net gains (losses) on investments at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
-$133.75K

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
Enterprise value$2.31B+91.4%
P/S10×+4.2×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's net gains (losses) on investments?
Axogen (AXGN) reported net gains (losses) on investments of -$33K in Q1 2026.
How has Axogen's net gains (losses) on investments changed year-over-year?
Axogen's net gains (losses) on investments decreased by 173.3% year-over-year, from $45K to -$33K.
What is the long-term trend for Axogen's net gains (losses) on investments?
Over 4 years (2021 to 2025), Axogen's net gains (losses) on investments has grown at a 48.3% compound annual growth rate (CAGR), from -$68K to $329K.
What does net gains (losses) on investments mean?
Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.